Последнее обновление :
19/11/2024
Противоаритмический, антиаритмический   Metoprolol tartrate  
Инъекция
Раствор для перорального приёма
Стабильность растворов Стабильность смесей Факторы, которые влияют на стабильность Совместимость Способы введения Библиография pdf
   Химическая структура  

Товарное название   Товарное название     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Beloc Австрия, Турция, Швейцария
Beloken Испания
Betaloc Великобритания, Польша
Lopresor Канада
Selokeen Голландия
Seloken Бельгия, Бразилия, Дания, Италия, Норвегия, Финляндия, Швеция
Библиография   Инъекция   Библиография : Metoprolol tartrate  
тип публикация
62 Журнал Pugh CB, Pabis DJ, Rodriguez C.
Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 123-125.
238 Журнал Belliveau PP, Shea BF, Scavone JM.
Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
Am J Hosp Pharm 1993 ; 50: 950-952.
240 Журнал Lam XM, Ward CA, de C du M?e CPR.
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Am J Health-Syst Pharm 1995 ; 52: 1904-1909.
921 Журнал Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1944 Журнал Hartman CA, Faria CE, Mago K.
Visual compatibility of bivalirudin with selected drugs.
Am J Health-Syst Pharm 2004 ; 61: 1774.
1964 Журнал Hartman CA, Baroletti SA, Churchill WW et al.
Visual compatibility of argatroban with selected drugs.
Am J Health-Syst Pharm 2002 ; 59: 1784-1785.
2267 Журнал Kraft MD, Johnson CE, Chung C, Julian F.
Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection.
Am J Health-Syst Pharm 2008 ; 65, 7: 636-638.
2269 Журнал Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
2346 Журнал Newland A.M, Mauro V.F, Alexander K.S.
Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents
Am J Health-Syst Pharm 2009 ; 66: 986-987.
3249 Журнал Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3372 Журнал Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3538 Журнал Gilcher Th, Heeb R M, Krämer I.
Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml.
Krankenhauspharmazie 2013 ; 11: 524-525.
3644 Лаборатория Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3838 Лаборатория Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
3879 Журнал Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E.
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
Int J Pharm Compound 2016 ; 20, 4 : 328-332.
3934 Лаборатория Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
GlaxoSmithKline Laboratoire 2016
4319 Журнал Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4433 Журнал Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
Clin Ther 2020 ; 42, 3: 475-485.

  Mentions Légales